Brown Advisory
AVNS icon

Brown Advisory’s Avanos Medical AVNS Stock Holding History

Brown Advisory’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.3M Buy
2,231,198
+295,396
+15% +$3.98M 0.05% 253
2025
Q4 		$21.7M Sell
1,935,802
-290,954
-13% -$3.33M 0.03% 316
2025
Q3 		$25.7M Buy
2,226,756
+417,921
+23% +$4.89M 0.03% 288
2025
Q2 		$22.1M Sell
1,808,835
-122,328
-6% -$1.54M 0.03% 301
2025
Q1 		$27.7M Buy
1,931,163
+26,069
+1% +$407K 0.04% 261
2024
Q4 		$30.3M Buy
1,905,094
+204,218
+12% +$4.04M 0.04% 281
2024
Q3 		$40.9M Buy
1,700,876
+30,093
+2% +$688K 0.05% 247
2024
Q2 		$33.3M Buy
1,670,783
+274,920
+20% +$5.35M 0.04% 259
2024
Q1 		$27.8M Buy
+1,395,863
New +$27M 0.04% 291
2021
Q2 		– Sell
-5,148
Closed -$225K – 1077
2021
Q1 		$225K Hold
5,148
– – ﹤0.01% 1004
2020
Q4 		$236K Buy
+5,148
New +$214K ﹤0.01% 930
2019
Q4 		– Sell
-6,245
Closed -$234K – 1042
2019
Q3 		$234K Sell
6,245
-237
-4% -$9.04K ﹤0.01% 911
2019
Q2 		$283K Sell
6,482
-106
-2% -$4.53K ﹤0.01% 883
2019
Q1 		$282K Sell
6,588
-273
-4% -$12.2K ﹤0.01% 1138
2018
Q4 		$308K Buy
6,861
+22
+0.3% +$1.15K ﹤0.01% 1065
2018
Q3 		$469K Sell
6,839
-100
-1% -$6.43K ﹤0.01% 1009
2018
Q2 		$397K Buy
6,939
+131
+2% +$6.92K ﹤0.01% 1032
2018
Q1 		$314K Buy
6,808
+69
+1% +$3.28K ﹤0.01% 958
2017
Q4 		$311K Sell
6,739
-1,049
-13% -$48.2K ﹤0.01% 1033
2017
Q3 		$351K Sell
7,788
-276
-3% -$11.8K ﹤0.01% 963
2017
Q2 		$318K Buy
8,064
+375
+5% +$14.2K ﹤0.01% 999
2017
Q1 		$293K Sell
7,689
-27
-0.3% -$1.05K ﹤0.01% 987
2016
Q4 		$286K Sell
7,716
-246
-3% -$8.79K ﹤0.01% 943
2016
Q3 		$275K Buy
7,962
+64
+0.8% +$2.24K ﹤0.01% 903
2016
Q2 		$256K Sell
7,898
-70
-0.9% -$2.14K ﹤0.01% 898
2016
Q1 		$229K Buy
+7,968
New +$212K ﹤0.01% 890

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Brown Advisory's AVNS Position: Q1 2026 in Review

Brown Advisory increased its Avanos Medical (AVNS) stake by 15% in Q1 2026, buying an estimated $3.98M and bringing the position to 2,231,198 shares worth $31.3M. The position accounts for 0.05% of the portfolio, ranked #253.

Brown Advisory first reported a position in AVNS in Q1 2016 and has held it in 26 quarters since. The position peaked at $40.9M in Q3 2024. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Brown Advisory held 2,231,198 shares of Avanos Medical worth $31.3M as of Q1 2026.
  • Brown Advisory bought 295,396 Avanos Medical shares in Q1 2026, an estimated $3.98M.
  • Avanos Medical made up 0.05% of Brown Advisory's portfolio in Q1 2026, its #253 holding.
  • Brown Advisory first reported a position in Avanos Medical in Q1 2016 and has held it in 26 quarters since.
  • Brown Advisory's Avanos Medical position peaked at $40.9M in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.